These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10731123)

  • 1. Use of aromatase inhibitors in precocious puberty.
    Feuillan P; Merke D; Leschek EW; Cutler GB
    Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
    Feuillan PP; Jones J; Cutler GB
    J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
    Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of familial male precocious puberty with spironolactone and testolactone.
    Laue L; Kenigsberg D; Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    N Engl J Med; 1989 Feb; 320(8):496-502. PubMed ID: 2492636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors in precocious puberty: rationale and experience to date.
    Eugster EA
    Treat Endocrinol; 2004; 3(3):141-51. PubMed ID: 16026110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
    Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L; Jones J; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testolactone treatment of precocious puberty in McCune-Albright syndrome.
    Foster CM; Pescovitz OH; Comite F; Feuillan P; Shawker T; Loriaux DL; Cutler GB
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):254-7. PubMed ID: 3925675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
    Roth C; Freiberg C; Zappel H; Albers N
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.
    Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome.
    Eugster EA; Shankar R; Feezle LK; Pescovitz OH
    J Pediatr Endocrinol Metab; 1999; 12(5):681-6. PubMed ID: 10703542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
    Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
    J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.
    Leschek EW; Jones J; Barnes KM; Hill SC; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):175-8. PubMed ID: 9920079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
    Merke DP; Keil MF; Jones JV; Fields J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1114-20. PubMed ID: 10720048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
    Laue L; Merke DP; Jones JV; Barnes KM; Hill S; Cutler GB
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3535-9. PubMed ID: 8855797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.
    Estrada A; Boyce AM; Brillante BA; Guthrie LC; Gafni RI; Collins MT
    Eur J Endocrinol; 2016 Nov; 175(5):477-483. PubMed ID: 27562402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.
    Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
    Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
    Mieszczak J; Lowe ES; Plourde P; Eugster EA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.